The pain field has seen its share of disappointment in developing new drugs. But over the past several months, the migraine field’s own search for new medications has turned out quite differently, with several innovative medications receiving regulatory approval. Those who treat migraine and people who suffer from it can now celebrate another triumph.
Published by RELIEF.
This story first appeared on the IASP Pain Research Forum and has been lightly edited for RELIEF.
